Cargando…
EPR-Effect Enhancers Strongly Potentiate Tumor-Targeted Delivery of Nanomedicines to Advanced Cancers: Further Extension to Enhancement of the Therapeutic Effect
For more than three decades, enhanced permeability and retention (EPR)-effect-based nanomedicines have received considerable attention for tumor-selective treatment of solid tumors. However, treatment of advanced cancers remains a huge challenge in clinical situations because of occluded or embolize...
Autores principales: | Islam, Waliul, Kimura, Shintaro, Islam, Rayhanul, Harada, Ayaka, Ono, Katsuhiko, Fang, Jun, Niidome, Takuro, Sawa, Tomohiro, Maeda, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229906/ https://www.ncbi.nlm.nih.gov/pubmed/34071552 http://dx.doi.org/10.3390/jpm11060487 |
Ejemplares similares
-
Augmentation of EPR Effect and Efficacy of Anticancer Nanomedicine by Carbon Monoxide Generating Agents
por: Fang, Jun, et al.
Publicado: (2019) -
Enhanced Permeability and Retention Effect as a Ubiquitous and Epoch-Making Phenomenon for the Selective Drug Targeting of Solid Tumors
por: Islam, Waliul, et al.
Publicado: (2022) -
Effect of Tumor Targeted-Anthracycline Nanomedicine, HPMA Copolymer-Conjugated Pirarubicin (P-THP) against Gynecological Malignancies
por: Yanazume, Shintaro, et al.
Publicado: (2022) -
Controlled Delivery of an Anti-Inflammatory Toxin to Macrophages by Mutagenesis and Nanoparticle Modification
por: Harada, Ayaka, et al.
Publicado: (2022) -
ATP exposure stimulates glutathione efflux as a necessary switch for NLRP3 inflammasome activation
por: Zhang, Tianli, et al.
Publicado: (2021)